The results of these studies indicate that Rg5 possesses the potential to enhance energy metabolism, facilitate lipid breakdown, and increase autophagic levels by activating LKB1/AMPK/mTOR, hence leading to the improvement of hepatic lipid accumulation in NAFLD. The gene discussed is STK11; the disease is metabolic dysfunction-associated steatotic liver disease.